Park Square Capital has held a final close for its fourth subordinated debt fund, Park Square Capital Partners IV (PSCP IV), on €1.8bn, surpassing its €1.5bn initial target.
Buyout reportedly values the pharmaceutical glass packaging producer at around €900m
Vehicle will co-invest in European tech scale-ups alongside the venture capital funds in which it is invested
Procuritas will become the majority shareholder, while the founders of the companies will have a significant minority ownership of the merged entity
ProFounders Capital scores 25x money on the listing; other investors include Partech